Latest Defense News

Southern Cross Gold Consolidated Ltd has reported extraordinary drill results from its Sunday Creek project in Victoria, revealing ultra-high-grade gold and antimony mineralization that significantly expands the discovery footprint.

Aurora Labs has signed a Memorandum of Understanding with Mayman Aerospace to jointly develop 3D-printed micro gas turbines for advanced VTOL aircraft, marking its strategic entry into the U.S. aerospace sector.

Amaero Ltd updates its financial outlook, targeting positive EBITDA by FY2027 and reaffirming a A$72 million capital investment plan despite delays in US Department of Defense contracts.

Pioneer Lithium has launched a two-phase soil sampling program at its Skull Creek Uranium Project in Colorado, aiming to define drill-ready uranium targets amid growing US government support for domestic supply.

MA Financial Group is set to acquire Melbourne-based IP Generation, adding $2 billion in assets and boosting its real estate management platform to over $12 billion AUM. The deal is expected to enhance earnings in FY25 and deepen MA’s presence in the retail real estate sector.

Southern Cross Gold Consolidated has completed the final tranche of a private placement, raising C$24.4 million to advance its Sunday Creek Gold-Antimony Project in Australia. The funds will support drilling, development, and economic assessment milestones through 2027.

Almonty Industries posted a modest revenue rise in Q1 2025 but faced a steep net loss due to warrant revaluation, while securing key U.S. defense contracts and advancing its flagship Sangdong tungsten mine.

International Graphite Limited has received encouraging feedback from the U.S. Department of Defense on its proposal for up to US$7.5 million in funding to advance its graphite mine-to-market strategy, potentially securing a vital supply chain from Western Australia to the U.S.

Electro Optic Systems has secured a €31 million contract for its flagship Slinger Counter-Drone Remote Weapon System, marking its largest naval order to date from a Western European government.

Cynata Therapeutics confirms that the recent FDA orphan-drug exclusivity granted to Ryoncil® will not block approval of its CYP-001 therapy, highlighting key differences in drug composition and patient indications.

Mesoblast has been granted a seven-year orphan-drug exclusivity by the FDA for its cell therapy Ryoncil, reinforcing its market position in treating steroid-refractory acute graft versus host disease in children.

Southern Cross Gold has successfully closed the second tranche of its C$143 million private placement, securing nearly C$30 million to fund critical milestones at its Sunday Creek Gold-Antimony Project in Australia.